| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 49.230 | 90.038 | 89.946 | 97.504 | 88.057 | 102.042 | 102.067 | 80.755 |
| Total Income - EUR | - | - | 49.451 | 90.358 | 90.956 | 98.388 | 89.820 | 103.191 | 103.715 | 80.842 |
| Total Expenses - EUR | - | - | 30.120 | 52.670 | 15.322 | 10.467 | 9.292 | 23.170 | 17.449 | 49.024 |
| Gross Profit/Loss - EUR | - | - | 19.331 | 37.688 | 75.634 | 87.921 | 80.529 | 80.021 | 86.266 | 31.817 |
| Net Profit/Loss - EUR | - | - | 16.236 | 36.711 | 74.734 | 86.938 | 79.632 | 79.021 | 72.546 | 27.283 |
| Employees | - | - | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Aktiv Pharma Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 1.990 | 1.133 | 652 | 212 | 0 | 0 | 0 | 414 |
| Current Assets | - | - | 25.960 | 55.345 | 87.242 | 107.281 | 184.673 | 87.960 | 78.794 | 45.153 |
| Inventories | - | - | 0 | 0 | 0 | 61 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 6.814 | 53.230 | 24.412 | 44.676 | 54.917 | 30.540 | 37.843 |
| Cash | - | - | 25.960 | 48.531 | 34.012 | 82.809 | 139.997 | 33.043 | 48.254 | 7.310 |
| Shareholders Funds | - | - | 16.280 | 52.703 | 74.795 | 106.271 | 183.487 | 86.660 | 72.547 | 40.584 |
| Social Capital | - | - | 44 | 54 | 53 | 52 | 51 | 51 | 51 | 50 |
| Debts | - | - | 11.669 | 3.775 | 13.099 | 1.222 | 1.186 | 1.299 | 6.247 | 4.982 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7022 - 7022" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Aktiv Pharma Srl